Drugs / Pfs25 VLP-FhCMB
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02013687 | Oct 2013 → Aug 2014 | malaria | Fraunhofer, Center for Molecular Biotechnology | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pfs25 VLP-FhCMB | “This Pfs25 VLP-FhCMB vaccine candidate has been engineered and manufactured in Nicotiana benthamiana plants at pilot plant scale under current Good Manufacturing Practice guidelines.” PMID 30126674 ↗ Aug 2018 |
| Modality | Vaccine | “This Pfs25 VLP-FhCMB vaccine candidate has been engineered and manufactured in Nicotiana benthamiana plants at pilot plant scale under current Good Manufacturing Practice guidelines.” PMID 30126674 ↗ Aug 2018 |